Corcept Therapeutics Incorporated
CORTNASDAQHealthcare● Active
$72.62
$-2.27(-3.03%)
Market Cap$7.8B
P/E Ratio—
52W High$91
52W Low$28.66
Corcept Therapeutics Incorporated（CORT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CORT · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.76B | $0.68B | $0.48B | $0.40B | $0.37B |
| Cost of Revenue | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Gross Profit | $0.75B | $0.66B | $0.48B | $0.40B | $0.36B |
| Gross Margin %(computed) | 98.30% | 98.39% | 98.66% | 98.66% | 98.56% |
| Operating Expenses | |||||
| R&D Expenses | $0.25B | $0.25B | $0.18B | $0.13B | $0.11B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.70B | $0.53B | $0.37B | $0.28B | $0.24B |
| Operating Income | $0.04B | $0.14B | $0.11B | $0.11B | $0.12B |
| Operating Margin %(computed) | 5.88% | 20.29% | 22.24% | 28.03% | 34.01% |
| Interest Income | $0.00B | $0.02B | $0.02B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.07B | $0.16B | $0.12B | $0.12B | $0.13B |
| Income Tax Expense | ($0.03B) | $0.02B | $0.02B | $0.01B | $0.01B |
| Net Income | $0.10B | $0.14B | $0.11B | $0.10B | $0.11B |
| Net Margin %(computed) | 13.09% | 20.70% | 22.00% | 25.24% | 30.74% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.95 | $1.35 | $1.02 | $0.95 | $0.97 |
| Wtd Avg Shares | 0.10B | 0.10B | 0.10B | 0.11B | 0.12B |
| EBITDA | $0.05B | $0.14B | $0.11B | $0.11B | $0.13B |
| EBITDA Margin %(computed) | 6.13% | 20.49% | 22.46% | 28.34% | 34.96% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Corcept Therapeutics Incorporated
关于Corcept Therapeutics Incorporated（CORT）损益表
Corcept Therapeutics Incorporated（CORT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CORT实现营收$0.76B，毛利润$0.75B（毛利率98.30%），净利润$0.10B（净利率13.09%）。
常见问题
CORT · 4 问Corcept Therapeutics Incorporated（CORT）2025财年营收为$0.76B，同比up12.8%。
CORT revenueCORT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08